FDA amps sleeping pill scrutiny
Popular medications such as Ambien and Lunesta are destined for tougher warning labels.
Medication will be used to treat two severe forms of epilepsy.
FDA focuses on developing drugs that target the underlying genetic causes of cancer.
Researcher calls the benefits of ocrelizumab 'quite stunning.'